^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Sema4 Signal®

    Company:
    GeneDx
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    Sema4 Signal is a family of data-driven precision oncology solutions incorporating advanced analytics, digital tools, and exome-based genomic testing. With its comprehensive suite of offerings, Sema4 Signal enables a holistic approach to deliver precision medicine throughout a patient’s journey, from assessing the risk of cancer to analyzing cancer for treatment options and long-term monitoring.
    Cancer:
    Solid Tumor
    Gene:
    MSI (Microsatellite instability), PD-L1 (Programmed death ligand 1), TMB (Tumor Mutational Burden)
    Method:
    Exome-based genomic testing